S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
Log in

Cronos Group Stock Price, Forecast & Analysis (NASDAQ:CRON)

$6.70
+0.56 (+9.12 %)
(As of 11/19/2019 04:00 PM ET)
Today's Range
$6.09
Now: $6.70
$7.00
50-Day Range
$6.14
MA: $8.25
$9.36
52-Week Range
$6.04
Now: $6.70
$25.10
Volume17.22 million shs
Average Volume8.37 million shs
Market Capitalization$2.30 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.4
Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. Read More…

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorFinance
Current SymbolNASDAQ:CRON
CUSIPN/A
CIKN/A
Phone212-590-9070

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$12.12 million
Book Value$0.91 per share

Profitability

Net Income$-14,640,000.00
Net Margins4,086.41%

Miscellaneous

Employees291
Market Cap$2.30 billion
Next Earnings Date3/24/2020 (Estimated)
OptionableOptionable

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.


Cronos Group (NASDAQ:CRON) Frequently Asked Questions

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for Cronos Group.

What price target have analysts set for CRON?

13 Wall Street analysts have issued twelve-month price targets for Cronos Group's shares. Their forecasts range from $12.00 to $24.00. On average, they expect Cronos Group's share price to reach $16.80 in the next twelve months. This suggests a possible upside of 150.8% from the stock's current price. View Analyst Price Targets for Cronos Group.

What is the consensus analysts' recommendation for Cronos Group?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating, 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cronos Group.

Has Cronos Group been receiving favorable news coverage?

Media headlines about CRON stock have been trending extremely negative this week, InfoTrie reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cronos Group earned a news impact score of -4.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Cronos Group.

Are investors shorting Cronos Group?

Cronos Group saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 48,660,000 shares, an increase of 16.3% from the September 30th total of 41,840,000 shares. Based on an average daily volume of 5,080,000 shares, the short-interest ratio is currently 9.6 days. Approximately 27.1% of the company's stock are short sold. View Cronos Group's Current Options Chain.

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Dollar Tree (DLTR), Aphria (APHA), NVIDIA (NVDA), Micron Technology (MU), Advanced Micro Devices (AMD), Alibaba Group (BABA) and KushCo (KSHB).

Who are Cronos Group's key executives?

Cronos Group's management team includes the folowing people:
  • Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)
  • Mr. David Hsu, Chief Operating Officer
  • Ms. Xiuming Shum, Gen. Counsel & Corp. Sec.
  • Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.
  • Mr. William Hilson, Chief Commercial Officer

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.19%), SG Americas Securities LLC (0.19%), Alberta Investment Management Corp (0.11%), Essex Investment Management Co. LLC (0.07%), Commonwealth Equity Services LLC (0.05%) and CIBC Asset Management Inc (0.03%).

Which major investors are selling Cronos Group stock?

CRON stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Exane Derivatives, Sigma Planning Corp, Benjamin F. Edwards & Company Inc., Cetera Advisors LLC, SeaCrest Wealth Management LLC and Cetera Advisor Networks LLC.

Which major investors are buying Cronos Group stock?

CRON stock was acquired by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Essex Investment Management Co. LLC, Alberta Investment Management Corp, Signition LP, Wedbush Securities Inc., Traynor Capital Management Inc., Valeo Financial Advisors LLC and Creative Planning.

How do I buy shares of Cronos Group?

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $6.70.

How big of a company is Cronos Group?

Cronos Group has a market capitalization of $2.30 billion and generates $12.12 million in revenue each year. The company earns $-14,640,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis. Cronos Group employs 291 workers across the globe.View Additional Information About Cronos Group.

What is Cronos Group's official website?

The official website for Cronos Group is http://www.thecronosgroup.com/.

How can I contact Cronos Group?

Cronos Group's mailing address is 720 KING STREET W SUITE 320, TORONTO A6, M5V 2T3. The company can be reached via phone at 212-590-9070.


MarketBeat Community Rating for Cronos Group (NASDAQ CRON)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  371 (Vote Outperform)
Underperform Votes:  447 (Vote Underperform)
Total Votes:  818
MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe CRON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel